Correlation Between Carl Zeiss and Sartorius Stedim

Can any of the company-specific risk be diversified away by investing in both Carl Zeiss and Sartorius Stedim at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Carl Zeiss and Sartorius Stedim into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Carl Zeiss Meditec and Sartorius Stedim Biotech, you can compare the effects of market volatilities on Carl Zeiss and Sartorius Stedim and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Carl Zeiss with a short position of Sartorius Stedim. Check out your portfolio center. Please also check ongoing floating volatility patterns of Carl Zeiss and Sartorius Stedim.

Diversification Opportunities for Carl Zeiss and Sartorius Stedim

0.16

Correlation Coefficient

Carl Zeiss  Sartorius Stedim

Average diversification

The 3 months correlation between Carl and Sartorius is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Carl Zeiss Meditec and Sartorius Stedim Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sartorius Stedim Biotech and Carl Zeiss is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Carl Zeiss Meditec are associated (or correlated) with Sartorius Stedim. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sartorius Stedim Biotech has no effect on the direction of Carl Zeiss i.e., Carl Zeiss and Sartorius Stedim go up and down completely randomly.

Pair Corralation between Carl Zeiss and Sartorius Stedim

Assuming the 90 days horizon Carl Zeiss Meditec is expected to under-perform the Sartorius Stedim. But the pink sheet apears to be less risky and, when comparing its historical volatility, Carl Zeiss Meditec is 1.13 times less risky than Sartorius Stedim. The pink sheet trades about -0.13 of its potential returns per unit of risk. The Sartorius Stedim Biotech is currently generating about -0.1 of returns per unit of risk over similar time horizon. If you would invest  24,180  in Sartorius Stedim Biotech on May 3, 2025 and sell it today you would lose (4,028) from holding Sartorius Stedim Biotech or give up 16.66% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Carl Zeiss Meditec  vs.  Sartorius Stedim Biotech

Carl Zeiss Meditec

Risk-Adjusted Performance

Very Weak

Over the last 90 days Carl Zeiss Meditec has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in September 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Sartorius Stedim Biotech

Risk-Adjusted Performance

Very Weak

Over the last 90 days Sartorius Stedim Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's technical indicators remain nearly stable which may send shares a bit higher in September 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Carl Zeiss and Sartorius Stedim

The main advantage of trading using opposite Carl Zeiss and Sartorius Stedim positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Carl Zeiss position performs unexpectedly, Sartorius Stedim can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sartorius Stedim will offset losses from the drop in Sartorius Stedim's long position.

The idea behind Carl Zeiss Meditec and Sartorius Stedim Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.